Evidence map›Paper›PMID 20634197›Full record

ArticleHuman molecular genetics2010

Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.

Federico Canzian, David G Cox, V Wendy Setiawan, Daniel O Stram, Regina G Ziegler, Laure Dossus, Lars Beckmann, Hélène Blanché, Aurelio Barricarte, Christine D Berg and 35 more

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Correlations between theOncology letters · 2016
    Article
  6. Article
  7. Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2016
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Estrogen metabolism and risk of breast cancer in postmenopausal women.Journal of the National Cancer Institute · 2012
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors at 20 institutions in 12 countries.

Federico CanzianGerman Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
David G Cox
V Wendy Setiawan
Daniel O Stram
Regina G Ziegler
Laure Dossus
Lars Beckmann
Hélène Blanché
Aurelio Barricarte
Christine D Berg
Sheila Bingham
Julie Buring
Saundra S Buys
Eugenia E Calle
Stephen J Chanock
Françoise Clavel-Chapelon
John Oliver L DeLancey
W Ryan Diver
Miren Dorronsoro
Christopher A Haiman
Göran Hallmans
Susan E Hankinson
David J Hunter
Anika Hüsing
Claudine Isaacs
Kay-Tee Khaw
Laurence N Kolonel
Peter Kraft
Loïc Le Marchand
Eiliv Lund
Kim Overvad
Salvatore Panico
Petra H M Peeters
Michael Pollak
Michael J Thun
Anne Tjønneland
Dimitrios Trichopoulos
Rosario Tumino
Meredith Yeager
Robert N Hoover
Elio Riboli
Gilles Thomas
Brian E Henderson
Rudolf Kaaks
Heather Spencer Feigelson
American Cancer Society · USUniversity of Southern California · USDivision of Cancer Epidemiology and GeneticsGerman Cancer Research Center · DEHarvard University · USHeidelberg University · DEImperial College London · GBUniversity of Cambridge · GBUniversity of Utah · USAarhus University Hospital · DKAcademy of Athens · GRAzienda Usl 8 Arezzo · ITBrigham and Women's Hospital · USCancer Genetics (United States) · USCancer Research Center · USDanish Cancer Society · DKFederico II University Hospital · ITFondation Jean Dausset-CEPH · FRGeorgetown University · USInstitut Gustave Roussy · FR

Funding

Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3U01CA098758 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 2003 to 2010
$11.0M
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3U01CA098233 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI HUNTER, DAVID JOHN · 2003 to 2010
$10.8M
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3U01CA098216 · NCI · INTERNATIONAL AGENCY FOR RES ON CANCER · PI RIBOLI, ELIO · 2003 to 2011
$7.4M
Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.U01CA098710 · NCI · AMERICAN CANCER SOCIETY, INC. · PI GAPSTUR, SUSAN M · 2003 to 2011
$4.2M
Intramural NIH HHSMedical Research Council G0401527NCI NIH HHS U01 CA098216NCI NIH HHS U01 CA098233NCI NIH HHS U01 CA098710NCI NIH HHS U01 CA098758NCI NIH HHS U01-CA98216NCI NIH HHS U01-CA98233NCI NIH HHS U01-CA98710NCI NIH HHS U01-CA98758
6 · The paper itself

Abstract

There is extensive evidence that increases in blood and tissue concentrations of steroid hormones and of insulin-like growth factor I (IGF-I) are associated with breast cancer risk. However, studies of common variation in genes involved in steroid hormone and IGF-I metabolism have yet to provide convincing evidence that such variants predict breast cancer risk. The Breast and Prostate Cancer Cohort Consortium (BPC3) is a collaboration of large US and European cohorts. We genotyped 1416 tagging single nucleotide polymorphisms (SNPs) in 37 steroid hormone metabolism genes and 24 IGF-I pathway genes in 6292 cases of breast cancer and 8135 controls, mostly Caucasian, postmenopausal women from the BPC3. We also imputed 3921 additional SNPs in the regions of interest. None of the SNPs tested was significantly associated with breast cancer risk, after correction for multiple comparisons. The results remained null when cases and controls were stratified by age at diagnosis/recruitment, advanced or nonadvanced disease, body mass index, with or without in situ cases; or restricted to Caucasians. Among 770 estrogen receptor-negative cases, an SNP located 3' of growth hormone receptor (GHR) was marginally associated with increased risk after correction for multiple testing (P(trend) = 1.5 × 10(-4)). We found no significant overall associations between breast cancer and common germline variation in 61 genes involved in steroid hormone and IGF-I metabolism in this large, comprehensive study. Although previous studies have shown that variations in these genes can influence endogenous hormone levels, the magnitude of the effect of single SNPs does not appear to be sufficient to alter breast cancer risk.

Indexed as

Genetic Predisposition to DiseaseAgedBreast NeoplasmsCohort StudiesFemaleGonadal Steroid HormonesHaplotypesHumansInsulin-Like Growth Factor IMaleMiddle AgedNational Cancer Institute (U.S.)Polymorphism, Single NucleotideProstatic NeoplasmsQuality ControlRisk FactorsGonadal Steroid HormonesInsulin-Like Growth Factor I

Identifiers

PMID20634197
PMCPMC2935856
OpenAlexW2125583020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.